TG Therapeutics Inc. (TGTX)
NASDAQ: TGTX
· Real-Time Price · USD
36.70
0.04 (0.11%)
At close: Oct 03, 2025, 3:59 PM
36.66
-0.12%
After-hours: Oct 03, 2025, 07:33 PM EDT
0.11% (1D)
| Bid | 36.7 |
| Market Cap | 5.82B |
| Revenue (ttm) | 454.07M |
| Net Income (ttm) | 60.46M |
| EPS (ttm) | 0.38 |
| PE Ratio (ttm) | 96.59 |
| Forward PE | 20.6 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 37.3 |
| Volume | 1,330,249 |
| Avg. Volume (20D) | 2,217,204 |
| Open | 36.62 |
| Previous Close | 36.66 |
| Day's Range | 36.37 - 37.28 |
| 52-Week Range | 21.16 - 46.48 |
| Beta | 1.97 |
| Ex-Dividend Date | n/a |
About TGTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TGTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TGTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTG Therapeutics Inc. is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+6.66%
TG Therapeutic shares are trading higher after the...
Unlock content with
Pro Subscription
2 months ago
-17.99%
TG Therapeutics shares are trading lower after the company reported worse-than-expected Q2 EPS and sales.
